Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

BACKGROUND: Both oral contraceptive pills (OCPs) and estradiol valerate (E2) have been used to schedule a gonadotropin-releasing hormone antagonist in vitro fertilization (IVF) cycles. Since the suppression of follicle-stimulating hormone by OCPs can stay 5-7 days after stopping the pills, it seems...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Reprod Biomed
Autori principali: Shahrokh Tehrani Nejad, Ensieh, Bakhtiari Ghaleh, Fatemeh, Eslami, Bita, Haghollahi, Fedyeh, Bagheri, Maryam, Masoumi, Masoumeh
Natura: Artigo
Lingua:Inglês
Pubblicazione: Research and Clinical Center for Infertility 2018
Soggetti:
Short Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6163045/
https://ncbi.nlm.nih.gov/pubmed/30288488
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi